Evidence map›Paper›PMID 24395925›Full record

ArticleJournal of lipid research2014

Obesity and lipid stress inhibit carnitine acetyltransferase activity.

Sarah E Seiler, Ola J Martin, Robert C Noland, Dorothy H Slentz, Karen L DeBalsi, Olga R Ilkayeva, Jie An, Christopher B Newgard, Timothy R Koves, Deborah M Muoio

Open access · hybridAbstract read
In one paragraph

Article in Journal of lipid research, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 62 papers.

0numbers the graph read from it
0cells of the map it votes in
62citing papers in PubMed
6.9field-weighted citation impact, top 2% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

62 citing papers in PubMed, 103 citations in OpenAlex.

  1. Trial
  2. Metabolic Inflexibility with Obesity and the Effects of Fenofibrate on Skeletal Muscle Fatty Acid Oxidation.Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme · 2017
    Trial
  3. Trial
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Atlas of lysine acetylation in the mouse.bioRxiv : the preprint server for biology · 2026
    Article
  10. PANoptosis in diabetes: immunometabolic insights and treatments.Apoptosis : an international journal on programmed cell death · 2026
    Review
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

2 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 2 countries.

Sarah E SeilerDepartment of Pharmacology and Cancer Biology, Duke University, Durham, NC 27704.
Ola J Martin
Robert C Noland
Dorothy H Slentz
Karen L DeBalsi
Olga R Ilkayeva
Jie An
Christopher B Newgard
Timothy R Koves
Deborah M Muoio
Duke University · USPennington Biomedical Research Center · USSanford Burnham Prebys Medical Discovery Institute · US

Funding

TARGETED RESPONSIVE MR AND PET AGENTS FOR B-CELL IMAGINGP01DK058398 · NIDDK · UNIVERSITY OF TEXAS SW MED CTR/DALLAS · PI NEWGARD, CHRISTOPHER B · 2000 to 2016
$26.1M
Role of Carnitine Acetyltransferase in Mitochondrial and Metabolic FunctionR01DK089312 · NIDDK · DUKE UNIVERSITY · PI DEBORAH M MUOIO · 2010 to 2026
$7.8M
Role of carnitine acetyltransferase in mitochondrial function and insulin actionF32DK080609 · NIDDK · DUKE UNIVERSITY · PI NOLAND, ROBERT CHARLES · 2007 to 2008
$101k
NIDDK NIH HHS 2P01-DK058398NIDDK NIH HHS F32 DK080609NIDDK NIH HHS P01 DK058398NIDDK NIH HHS R01 DK089312
6 · The paper itself

Abstract

Carnitine acetyltransferase (CrAT) is a mitochondrial matrix enzyme that catalyzes the interconversion of acetyl-CoA and acetylcarnitine. Emerging evidence suggests that this enzyme functions as a positive regulator of total body glucose tolerance and muscle activity of pyruvate dehydrogenase (PDH), a mitochondrial enzyme complex that promotes glucose oxidation and is feedback inhibited by acetyl-CoA. Here, we used tandem mass spectrometry-based metabolic profiling to identify a negative relationship between CrAT activity and muscle content of lipid intermediates. CrAT specific activity was diminished in muscles from obese and diabetic rodents despite increased protein abundance. This reduction in enzyme activity was accompanied by muscle accumulation of long-chain acylcarnitines (LCACs) and acyl-CoAs and a decline in the acetylcarnitine/acetyl-CoA ratio. In vitro assays demonstrated that palmitoyl-CoA acts as a direct mixed-model inhibitor of CrAT. Similarly, in primary human myocytes grown in culture, nutritional and genetic manipulations that promoted mitochondrial influx of fatty acids resulted in accumulation of LCACs but a pronounced decrease of CrAT-derived short-chain acylcarnitines. These results suggest that lipid-induced antagonism of CrAT might contribute to decreased PDH activity and glucose disposal in the context of obesity and diabetes.

Indexed as

Acetyl Coenzyme AAnimalsCarnitineCarnitine O-AcetyltransferaseCarnitine O-PalmitoyltransferaseCells, CulturedDiabetes MellitusHumansLipid MetabolismMaleMuscle Fibers, SkeletalObesityPyruvate Dehydrogenase ComplexRats, WistarRats, ZuckerAcetyl Coenzyme AacylcarnitineCarnitineCarnitine O-AcetyltransferaseCarnitine O-PalmitoyltransferasePyruvate Dehydrogenase Complexacetyl-coenzyme Aacylcarnitinesdiabeteslipid metabolismmitochondriamuscle

Identifiers

PMID24395925
PMCPMC3966698
OpenAlexW2153791770

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.